Tomocube
Daejeon
About Tomocube
Tomocube’s is dedicated to delivering products that can enhance biological and medical research via novel optical solutions that can assist Tomocube in understanding, diagnosing, and treating human diseases. Current optical microscopes only provide users with a 2D view of their sample. To get a 3D view, users must use expensive and invasive electron or confocal microscopes, which require extensive pre-preparation of samples and are not amenable to dynamic samples such as live cells. Their platform enables researchers to measure nanoscale, real-time, dynamic images of individual living cells without the need for sample preparation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $22.7M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2021)
- Website: tomocube.com
- Phone: +82428631100
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/tomocube-57498 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.